Akèy › Maladi Endokrin › Texas › Houston
Etid klinik pou Maladi Endokrin nan Houston, TX
6 etid pou Maladi Endokrin ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
Ap rekriteFaz 3
- Ascendis Pharma Investigational Site, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Ap rekriteFaz 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
Study of BHV-1300 in Graves' Disease
Ap rekriteFaz 1
- Site-106, Houston
- Site-101, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
Rare and Atypical Diabetes Network
Ap rekriteEtid obsèvasyon
- Baylor College of Medicine, Houston
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Ap rekriteEtid obsèvasyon
- University of Texas MD Anderson Cancer Center, Houston
Etid Maladi Endokrin nan lòt vil
- Washington, DC5 etid
- Chicago, IL4 etid
- Miami, FL3 etid
- San Antonio, TX3 etid
- Seattle, WA3 etid
- Boston, MA3 etid
- New York City, NY3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.